Magnesium in PDB 4qw3: Ycp BETA5-C63F Mutant in Complex with Bortezomib
Enzymatic activity of Ycp BETA5-C63F Mutant in Complex with Bortezomib
All present enzymatic activity of Ycp BETA5-C63F Mutant in Complex with Bortezomib:
3.4.25.1;
Protein crystallography data
The structure of Ycp BETA5-C63F Mutant in Complex with Bortezomib, PDB code: 4qw3
was solved by
E.M.Huber,
W.Heinemeyer,
M.Groll,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
15.00 /
2.90
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
138.140,
299.960,
146.570,
90.00,
113.18,
90.00
|
R / Rfree (%)
|
18.3 /
21.7
|
Other elements in 4qw3:
The structure of Ycp BETA5-C63F Mutant in Complex with Bortezomib also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
(pdb code 4qw3). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 5 binding sites of Magnesium where determined in the
Ycp BETA5-C63F Mutant in Complex with Bortezomib, PDB code: 4qw3:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
Magnesium binding site 1 out
of 5 in 4qw3
Go back to
Magnesium Binding Sites List in 4qw3
Magnesium binding site 1 out
of 5 in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Ycp BETA5-C63F Mutant in Complex with Bortezomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Mg301
b:65.2
occ:1.00
|
O
|
G:MET125
|
2.3
|
59.7
|
1.0
|
OG1
|
G:THR8
|
2.5
|
49.8
|
1.0
|
O
|
G:ARG122
|
2.7
|
44.4
|
1.0
|
O
|
G:TYR119
|
2.9
|
49.1
|
1.0
|
CG2
|
G:THR8
|
3.2
|
53.2
|
1.0
|
O
|
G:ALA123
|
3.3
|
57.5
|
1.0
|
CB
|
G:THR8
|
3.4
|
52.1
|
1.0
|
C
|
G:MET125
|
3.4
|
57.3
|
1.0
|
C
|
G:ALA123
|
3.7
|
55.9
|
1.0
|
CA
|
G:ALA123
|
3.8
|
53.6
|
1.0
|
C
|
G:ARG122
|
3.8
|
50.3
|
1.0
|
N
|
G:THR8
|
4.0
|
55.0
|
1.0
|
C
|
G:TYR119
|
4.1
|
48.5
|
1.0
|
CA
|
G:ARG126
|
4.1
|
53.2
|
1.0
|
N
|
G:ARG126
|
4.2
|
54.1
|
1.0
|
N
|
G:ALA123
|
4.2
|
50.5
|
1.0
|
N
|
G:MET125
|
4.3
|
59.0
|
1.0
|
CA
|
G:THR8
|
4.3
|
53.4
|
1.0
|
CA
|
G:MET125
|
4.5
|
60.5
|
1.0
|
CD
|
G:PRO127
|
4.5
|
50.6
|
1.0
|
N
|
G:TYR124
|
4.7
|
58.7
|
1.0
|
C
|
G:ARG126
|
4.8
|
51.8
|
1.0
|
CA
|
G:TYR119
|
4.9
|
47.5
|
1.0
|
N
|
G:PRO127
|
5.0
|
50.1
|
1.0
|
|
Magnesium binding site 2 out
of 5 in 4qw3
Go back to
Magnesium Binding Sites List in 4qw3
Magnesium binding site 2 out
of 5 in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Ycp BETA5-C63F Mutant in Complex with Bortezomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Mg201
b:43.6
occ:1.00
|
OE1
|
J:GLN118
|
3.3
|
58.7
|
1.0
|
O
|
J:THR124
|
3.7
|
55.3
|
1.0
|
CB
|
J:ASP120
|
3.9
|
49.4
|
1.0
|
CG
|
J:ASP120
|
4.0
|
51.4
|
1.0
|
OD2
|
J:ASP120
|
4.0
|
54.1
|
1.0
|
N
|
J:ASP120
|
4.1
|
50.2
|
1.0
|
CD
|
J:GLN118
|
4.1
|
53.7
|
1.0
|
CB
|
J:THR124
|
4.3
|
52.5
|
1.0
|
CG
|
J:GLN118
|
4.3
|
50.9
|
1.0
|
CG2
|
J:THR124
|
4.4
|
52.3
|
1.0
|
CE1
|
J:HIS133
|
4.4
|
50.3
|
1.0
|
O
|
J:GLN118
|
4.4
|
50.6
|
1.0
|
CG1
|
I:VAL35
|
4.6
|
56.1
|
1.0
|
CA
|
J:ASP120
|
4.6
|
48.5
|
1.0
|
C
|
J:THR124
|
4.6
|
51.4
|
1.0
|
OD1
|
J:ASP120
|
4.7
|
56.8
|
1.0
|
CD2
|
I:LEU28
|
4.7
|
54.6
|
1.0
|
C
|
J:ILE119
|
4.7
|
49.4
|
1.0
|
C
|
J:GLN118
|
4.8
|
47.3
|
1.0
|
OG
|
I:SER30
|
4.9
|
59.8
|
1.0
|
CA
|
J:ILE119
|
4.9
|
46.6
|
1.0
|
|
Magnesium binding site 3 out
of 5 in 4qw3
Go back to
Magnesium Binding Sites List in 4qw3
Magnesium binding site 3 out
of 5 in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Ycp BETA5-C63F Mutant in Complex with Bortezomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
N:Mg202
b:39.1
occ:1.00
|
O
|
N:SER169
|
2.6
|
44.9
|
1.0
|
O
|
N:ILE163
|
2.7
|
49.2
|
1.0
|
O
|
N:ASP166
|
2.8
|
54.9
|
1.0
|
NH1
|
N:ARG19
|
3.6
|
51.3
|
1.0
|
CD1
|
a:LEU34
|
3.7
|
56.9
|
1.0
|
C
|
N:SER169
|
3.8
|
48.3
|
1.0
|
C
|
N:ILE163
|
3.8
|
51.1
|
1.0
|
C
|
N:ASP166
|
3.9
|
49.7
|
1.0
|
CG2
|
N:ILE163
|
4.1
|
50.9
|
1.0
|
CA
|
N:GLY167
|
4.1
|
48.6
|
1.0
|
CZ
|
N:ARG19
|
4.3
|
51.4
|
1.0
|
O
|
N:GLY167
|
4.4
|
48.7
|
1.0
|
N
|
N:GLY167
|
4.4
|
47.9
|
1.0
|
C
|
N:GLY167
|
4.5
|
48.3
|
1.0
|
CA
|
N:ILE163
|
4.5
|
51.2
|
1.0
|
CA
|
N:GLY170
|
4.5
|
50.8
|
1.0
|
N
|
N:GLY170
|
4.6
|
49.4
|
1.0
|
NH2
|
N:ARG19
|
4.6
|
56.5
|
1.0
|
N
|
N:SER169
|
4.7
|
47.3
|
1.0
|
CA
|
N:SER169
|
4.8
|
45.3
|
1.0
|
N
|
N:LYS164
|
4.9
|
52.5
|
1.0
|
O
|
N:LYS164
|
4.9
|
50.8
|
1.0
|
N
|
N:ASP166
|
4.9
|
50.2
|
1.0
|
C
|
N:LYS164
|
4.9
|
52.8
|
1.0
|
CG
|
a:LEU34
|
4.9
|
57.0
|
1.0
|
CB
|
N:ILE163
|
5.0
|
51.0
|
1.0
|
|
Magnesium binding site 4 out
of 5 in 4qw3
Go back to
Magnesium Binding Sites List in 4qw3
Magnesium binding site 4 out
of 5 in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Ycp BETA5-C63F Mutant in Complex with Bortezomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Y:Mg302
b:66.0
occ:1.00
|
O
|
Y:ASP168
|
2.3
|
50.3
|
1.0
|
O
|
I:ASP204
|
2.3
|
59.0
|
1.0
|
O
|
Y:ALA165
|
2.4
|
61.9
|
1.0
|
O
|
Y:SER171
|
2.9
|
50.2
|
1.0
|
C
|
I:ASP204
|
3.2
|
62.9
|
1.0
|
C
|
Y:ASP168
|
3.2
|
52.9
|
1.0
|
C
|
Y:ALA165
|
3.6
|
57.2
|
1.0
|
CA
|
Y:ALA169
|
3.6
|
54.6
|
1.0
|
CA
|
I:ASP204
|
3.7
|
66.1
|
1.0
|
O
|
Y:HIS166
|
3.7
|
48.4
|
1.0
|
N
|
Y:ALA169
|
3.8
|
56.3
|
1.0
|
NH1
|
Y:ARG19
|
3.8
|
67.7
|
1.0
|
CB
|
I:ASP204
|
3.9
|
68.6
|
1.0
|
C
|
Y:ALA169
|
3.9
|
53.0
|
1.0
|
O
|
Y:ALA169
|
4.0
|
51.3
|
1.0
|
C
|
Y:SER171
|
4.0
|
51.4
|
1.0
|
C
|
Y:HIS166
|
4.2
|
54.0
|
1.0
|
OXT
|
I:ASP204
|
4.2
|
60.9
|
1.0
|
N
|
Y:ASP168
|
4.4
|
54.0
|
1.0
|
CA
|
Y:ASP168
|
4.4
|
52.9
|
1.0
|
CA
|
Y:ALA165
|
4.5
|
55.0
|
1.0
|
N
|
Y:SER171
|
4.5
|
52.7
|
1.0
|
N
|
Y:HIS166
|
4.5
|
58.9
|
1.0
|
CZ
|
Y:ARG19
|
4.5
|
67.3
|
1.0
|
CA
|
Y:HIS166
|
4.6
|
55.5
|
1.0
|
C
|
Y:ARG167
|
4.6
|
54.3
|
1.0
|
O
|
Y:ALA164
|
4.7
|
56.3
|
1.0
|
N
|
Y:TYR170
|
4.8
|
53.2
|
1.0
|
CA
|
Y:SER171
|
4.8
|
49.9
|
1.0
|
N
|
Y:ARG167
|
4.8
|
54.1
|
1.0
|
NH2
|
Y:ARG19
|
4.9
|
74.5
|
1.0
|
O
|
Y:ARG167
|
4.9
|
54.5
|
1.0
|
CB
|
Y:ALA169
|
4.9
|
55.1
|
1.0
|
CG
|
I:ASP204
|
5.0
|
67.9
|
1.0
|
N
|
Y:GLY172
|
5.0
|
49.9
|
1.0
|
|
Magnesium binding site 5 out
of 5 in 4qw3
Go back to
Magnesium Binding Sites List in 4qw3
Magnesium binding site 5 out
of 5 in the Ycp BETA5-C63F Mutant in Complex with Bortezomib
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Ycp BETA5-C63F Mutant in Complex with Bortezomib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
Z:Mg301
b:66.7
occ:1.00
|
O
|
Z:VAL198
|
2.5
|
58.1
|
1.0
|
O
|
Z:THR192
|
2.9
|
62.0
|
1.0
|
O
|
Z:HIS195
|
3.2
|
47.6
|
1.0
|
NH2
|
Z:ARG28
|
3.5
|
66.3
|
1.0
|
O
|
Z:ASP222
|
3.6
|
70.3
|
1.0
|
CG2
|
Z:THR192
|
3.6
|
66.5
|
1.0
|
C
|
Z:VAL198
|
3.6
|
60.2
|
1.0
|
C
|
Z:THR192
|
3.9
|
63.5
|
1.0
|
O
|
Z:ILE196
|
3.9
|
57.1
|
1.0
|
OD1
|
Z:ASP222
|
4.1
|
69.0
|
1.0
|
CA
|
Z:THR192
|
4.2
|
64.7
|
1.0
|
C
|
Z:ILE196
|
4.2
|
54.7
|
1.0
|
CA
|
Z:ILE196
|
4.2
|
55.0
|
1.0
|
C
|
Z:HIS195
|
4.2
|
52.0
|
1.0
|
NH2
|
H:ARG19
|
4.4
|
68.0
|
1.0
|
CZ
|
Z:ARG28
|
4.4
|
63.1
|
1.0
|
N
|
Z:VAL198
|
4.4
|
55.5
|
1.0
|
CA
|
Z:GLY199
|
4.5
|
60.2
|
1.0
|
N
|
Z:GLY199
|
4.5
|
60.0
|
1.0
|
CB
|
Z:THR192
|
4.5
|
65.2
|
1.0
|
C
|
Z:ASP222
|
4.5
|
70.1
|
1.0
|
NH1
|
Z:ARG28
|
4.6
|
60.0
|
1.0
|
O
|
Z:LYS220
|
4.6
|
62.4
|
1.0
|
CA
|
Z:VAL198
|
4.6
|
56.6
|
1.0
|
N
|
Z:ILE196
|
4.7
|
52.3
|
1.0
|
|
Reference:
E.M.Huber,
W.Heinemeyer,
M.Groll.
Bortezomib-Resistant Mutant Proteasomes: Structural and Biochemical Evaluation with Carfilzomib and Onx 0914. Structure 2015.
ISSN: ISSN 0969-2126
PubMed: 25599643
DOI: 10.1016/J.STR.2014.11.019
Page generated: Tue Aug 20 02:25:04 2024
|